LUNG CANCER THERAPY USING NATURALLY OCCURRING PRODUCTS AND NANOTECHNOLOGY

SYED SAIF IMAM; SYEDA TUBA IMAM; SMRITI AGARWAL; RISHABH KUMAR; MD YUSUF AMMAR; MD WASIF ATHAR; ARBAZ AKHTAR

doi:10.22159/ijms.2022.v10i4.44993

Authors

SYED SAIF IMAM Department of Pharmaceutical Sciences, HIMT College of Pharmacy, Knowledge Park-1, Greater Noida, Uttar Pradesh, India.
SYEDA TUBA IMAM Department of Obstetrics and Gynaecology, JLNMCH Mayaganj, Bhagalpur, Bihar, India.
SMRITI AGARWAL Department of Pharmaceutical Sciences, HIMT College of Pharmacy, Knowledge Park-1, Greater Noida, Uttar Pradesh, India.
RISHABH KUMAR Department of Pharmaceutical Sciences, HIMT College of Pharmacy, Knowledge Park-1, Greater Noida, Uttar Pradesh, India.
MD YUSUF AMMAR Department of Pharmaceutical Sciences, HIMT College of Pharmacy, Knowledge Park-1, Greater Noida, Uttar Pradesh, India.
MD WASIF ATHAR Department of Pharmaceutical Sciences, LLOYD College of Pharmacy, 11, Knowledge Park-2, Greater Noida, Uttar Pradesh, India.
ARBAZ AKHTAR Department of Pharmaceutical Sciences, HIMT College of Pharmacy, Knowledge Park-1, Greater Noida, Uttar Pradesh, India.

DOI:

https://doi.org/10.22159/ijms.2022.v10i4.44993

Keywords:

Theaflavins, Quercetin, Arctigenin, EGCG, Curcumin, Cinnamaldehyde, Lung Cancer, Nanotechnology

Abstract

Lung cancer is a severe type of cancer with highest mortality rate among all cancers. Natural products such as theaflavins, quercetin, arctigenin, EGCG, curcumin, and cinnamaldehyde are quite capable anti-inflammatory and anti-cancerous agents which are able to suppress ERK-MAPK, JAK-STAT, p38, AMPK, PI3K/Akt, MAPK, mTOR, STAT3, and Wnt/β-catenin signal transduction pathways. These APIs inhibit the inflammatory and proliferator enzymes such as COX-2, caspase-3, MMP-9, MMP-2, NF-κB, p53, Bcl-xL, Bcl-2,Mcl-1, miR-210, cyclin D1, iNOS, IL-1β, TNF-α, IFN-γ, IL-6, and IL-1α. All the above properties clearly show the anti-cancerous potential, but the problems arise because of their instability at gastrointestinal tract pH. All the compounds either degrade at gastric pH or loss their cancerous potential. New generation nanoparticles such as transferosomes are quite stable at 7.4 pH and its efficacy and drug entrapment potential are better than other conventional nanoparticle systems. If these APIs are added inside the nanovesicular structure of transferosomes and then loaded in pMDI canisters such as fluorocarbon polymerization (FCP), plasma-coated canisters with a better propellant such as HFA-134a and delivered with the help of spacers can cure lungs cancer economically, efficiently with minimal side effects and it also ensures that the cancer will not reoccur.

References

Available from: https://www.who.int/news-room/fact-sheets/detail/ cancer [Last accessed on 2022 Apr 10].

Kang SM, Sung HJ, Ahn JM, Park JY, Lee SY, Park CS, et al. The haptoglobin β chain as a supportive biomarker for human lung cancers. Mol Biosyst 2011;7:1167-75.

Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell 2002;1:49-52.

Gadgeel SM, Kalemkerian GP. Racial differences in lung cancer. Cancer Metastasis Rev 2003;22:39-46.

Kumar V, Abbas AK, Fausto N, Robbins SL, Cotran RS. In: Robbins and Cotran Pathologic Basis of Disease. 7thed. Philadelphia: Elsevier Saunders; 2005.

Gandara DR, Hammerman PS, Sos ML, Lara PN, Hirsch FR. Squamous cell lung cancer: From tumor genomics to cancer therapeutics. Clin Cancer Res 2015;21:2236-43.

Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow LQ, Downey RJ, et al. Small cell lung cancer. J Natl Compr Canc Netw 2013;11:78-98.

Rajdev K, Siddiqui AH, Ibrahim U, Patibandla P, Khan T, El-Sayegh D. An unusually aggressive large cell carcinoma of the lung: Undiagnosed until autopsy. Cureus 2018;10:e2202.

Lu G, Liao J, Yang G, Reuhl KR, Hao X, Yang CS. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res 2006;66:11494-501.

Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The ohsaki study. JAMA 2006;296:1255-65.

Granja A, Pinheiro M, Reis S. Epigallocatechin gallate nanodelivery systems for cancer therapy. Nutrients 2016;8:307.

Imam SS. The future of non-invasive ways to treat cancer. Int J Pharm Sci Res 2021;12:4684-96.

Yamada S, Tsukamoto S, Huang Y, Makio A, Kumazoe M, Yamashita S, et al. Epigallocatechin-3-O-gallate up-regulates microRNA-let- 7b expression by activating 67-kDa laminin receptor signaling in melanoma cells. Sci Rep 2016;6:19225.

Milligan SA, Burke P, Coleman DT, Bigelow RL, Steffan JJ, Carroll JL, et al. The green tea polyphenol, EGCG, potentiates the anti-proliferative activity of c-met and EGFR inhibitors in non-small cell lung cancer cells. Clin Cancer Res 2009;15:4885-94.

Zhang X, Min KW, Wimalasena J, Baek SJ. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate. J Cancer Res Clin Oncol 2012;138:2051-60.

Li W, Saud SM, Young MR, Chen G, Hua B. Targeting AMPK for cancer prevention and treatment. Oncotarget 2015;6:7365-78.

Zhang L, Xie J, Gan R, Wu Z, Luo H, Chen X, et al. Synergistic inhibition of lung cancer cells by EGCG and NF-κB inhibitor BAY11- 7082. J Cancer 2019;10:6543-56.

O’Neill EJ, Termini D, Albano A, Tsiani E. Anti-cancer properties of theaflavins. Molecules 2021;26:987.

Imam SS, Imam ST, Mdwasifathar KR, Kumar R, Ammar MY. Interaction between ACE 2 and SARS-Cov2, and use of EGCG and theaflavin to treat covid 19 in initial phases. Int J Curr Pharm Res 2022;14:5-10.

Imran A, Butt MS, Xiao H, Imran M, Rauf A, Mubarak MS, et al. Inhibitory effect of black tea (Camellia sinensis) theaflavins and thearubigins against HCT 116 colon cancer cells and HT 460 lung cancer cells. J Food Biochem 2019;43:e12822.

Park SK, Dahmer MK, Quasney MW. MAPK and JAK-STAT signaling pathways are involved in the oxidative stress-induced decrease in expression of surfactant protein genes. Cell Physiol Biochem 2012;30:334-46.

Shalini S, Dorstyn L, Dawar S, Kumar S. Old, new and emerging functions of caspases. Cell Death Differ 2015;22:526-39.

Shao J, Meng Q, Li Y. Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma. Onco Targets Ther 2016;9:4265-75.

Aggarwal BB, Yuan W, Li S, Gupta SC. Curcumin‐free turmeric exhibits anti‐inflammatory and anticancer activities: Identification of novel components of turmeric. Mol Nutr Food Res 2013;57:1529-42.

Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011;10:12.

Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Curcumin inhibits cyclooxygenase-2 transcription in bile acid-and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 1999;20:445-51.

Rao CV. Regulation of COX and LOX by curcumin. Adv Exp Med Biol 2007;595:213-26.

Hidaka H, Ishiko T, Furuhashi T, Kamohara H, Suzuki S, Miyazaki M, et al. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: Impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 2002;95:1206-14.

Panaro MA, Corrado A, Benameur T, Paolo CF, Cici D, Porro C. The emerging role of curcumin in the modulation of TLR-4 signaling pathway: Focus on neuroprotective and anti-rheumatic properties. Int J Mol Sci 2020;21:2299.

Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, et al. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3, 5-Bis (2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties. Int Immunopharmacol 2012;12:368-77.

Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evid Based Complement Alternat Med 2014;2014:642942.

Soufli I, Toumi R, Rafa H, Touil-Boukoffa C. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016;7:353-60.

Chao LK, Hua KF, Hsu HY, Cheng SS, Lin IF, Chen CJ, et al. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem Toxicol 2008;46:220-31.

Kim NY, Trinh NT, Ahn SG, Kim SA. Cinnamaldehyde protects against oxidative stress and inhibits the TNF α induced inflammatory response in human umbilical vein endothelial cells. Int J Mol Med 2020;46:449-57.

Pannee C, Chandhanee I, Wacharee L. Antiinflammatory effects of essential oil from the leaves of Cinnamomum cassia and cinnamaldehyde on lipopolysaccharide-stimulated J774A.1 cells. J Adv Pharm Technol Res 2014;5:164-70.

Maalik A, Khan FA, Mumtaz A, Mehmood A, Azhar S, Atif M, et al. Pharmacological applications of quercetin and its derivatives: A short review. Trop J Pharm Res 2014;13:1561-6.

Oh WJ, Endale M, Park SC, Cho JY, Rhee MH. Dual roles of quercetin in platelets: Phosphoinositide-3-kinase and MAP kinases inhibition, and cAMP-dependent vasodilator-stimulated phosphoprotein stimulation. Evid Based Complement Alternat Med 2012;2012:485262.

Bureau G, Longpré F, Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 2008;86:403-10.

Xiao X, Shi D, Liu L, Wang J, Xie X, Kang T, et al. Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS One 2011;6:e22934.

Endale M, Park SC, Kim S, Kim SH, Yang Y, Cho JY, et al. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology 2013;218:1452-67.

Yang D, Liu X, Liu M, Chi H, Liu J, Han H. Protective effects of quercetin and taraxasterol against H2O2-induced human umbilical vein endothelial cell injury in vitro. Exp Ther Med 2015;10:1253-60.

Yin Q, Wang L, Yu H, Chen D, Zhu W, Sun C. Pharmacological effects of polyphenol phytochemicals on the JAK-STAT signaling pathway. Front Pharmacol 2021;12:716672.

Zhao F, Wang L, Liu K. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway. J Ethnopharmacol 2009;122:457-62.

Lou C, Zhu Z, Zhao Y, Zhu R, Zhao H. Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/−9 and heparanase in MDA-MB-231 cells. Oncol Rep 2017;37:179-84.

Koundouros N, Poulogiannis G. Phosphoinositide 3-kinase/ Aktsignaling and redox metabolism in cancer. Front Oncol 2018;8:160.

Sun Y, Tan YJ, Lu ZZ, Li BB, Sun CH, Li T, et al. Arctigenin inhibits liver cancer tumorigenesis by inhibiting gankyrin expression via C/ EBPα and PPARα. Front Pharmacol 2018;9:268.

Maxwell T, Lee KS, Kim S, Nam KS. Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells. Int J Oncol 2018;52:1339-49.

Imam SS, Agarwal S. A pragmatic approach to treat lung cancer through loading theaflavin -3,3’-digallate and epigallocatechin gallate in spanlastic. Asian J Pharm Clin Res 2021;14:1-8.

Modi CD, Bharadia PD. Transfersomes: New dominants for transdermal drug delivery. Am J Pharm Tech Res 2012;2:71-91.